Literature DB >> 26408544

Leptin decreases heart rate associated with increased ventricular repolarization via its receptor.

Yen-Chang Lin1, Jianying Huang2, Stan Hileman3, Karen H Martin4, Robert Hull5, Mary Davis3, Han-Gang Yu6.   

Abstract

Leptin has been proposed to modulate cardiac electrical properties via β-adrenergic receptor activation. The presence of leptin receptors and adipocytes in myocardium raised a question as to whether leptin can directly modulate cardiac electrical properties such as heart rate and QT interval via its receptor. In this work, the role of local direct actions of leptin on heart rate and ventricular repolarization was investigated. We identified the protein expression of leptin receptors at cell surface of sinus node, atrial, and ventricular myocytes isolated from rat heart. Leptin at low doses (0.1-30 μg/kg) decreased resting heart rate; at high doses (150-300 μg/kg), leptin induced a biphasic effect (decrease and then increase) on heart rate. In the presence of high-dose propranolol (30 mg/kg), high-dose leptin only reduced heart rate and sometimes caused sinus pauses and ventricular tachycardia. The leptin-induced inhibition of resting heart rate was fully reversed by leptin antagonist. Leptin also increased heart rate-corrected QT interval (QTc), and leptin antagonist did not. In isolated ventricular myocytes, leptin (0.03-0.3 μg/ml) reversibly increased the action potential duration. These results supported our hypothesis that in addition to indirect pathway via sympathetic tone, leptin can directly decrease heart rate and increase QT interval via its receptor independent of β-adrenergic receptor stimulation. During inhibition of β-adrenergic receptor activity, high concentration of leptin in myocardium can cause deep bradycardia, prolonged QT interval, and ventricular arrhythmias.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  QT interval; leptin; leptin receptor; resting heart rate

Mesh:

Substances:

Year:  2015        PMID: 26408544      PMCID: PMC4666984          DOI: 10.1152/ajpheart.00623.2015

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  40 in total

Review 1.  Sympathetic and cardiorenal actions of leptin.

Authors:  W G Haynes; W I Sivitz; D A Morgan; S A Walsh; A L Mark
Journal:  Hypertension       Date:  1997-09       Impact factor: 10.190

2.  Dependency of premature ventricular contractions on heart rate.

Authors:  M V Pitzalis; F Mastropasqua; F Massari; A Passantino; C Forleo; G Luzzi; P Totaro; M De Nicolò; P Rizzon
Journal:  Am Heart J       Date:  1997-02       Impact factor: 4.749

3.  Cardiac failure and sudden death in the Framingham Study.

Authors:  W B Kannel; J F Plehn; L A Cupples
Journal:  Am Heart J       Date:  1988-04       Impact factor: 4.749

4.  Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity.

Authors:  F H Messerli; B D Nunez; H O Ventura; D W Snyder
Journal:  Arch Intern Med       Date:  1987-10

5.  QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathy.

Authors:  G Jermendy; M Z Koltai; G Pogátsa
Journal:  Acta Diabetol Lat       Date:  1990 Oct-Dec

Review 6.  Diagnosis and treatment of sick sinus syndrome.

Authors:  Victor Adán; Loren A Crown
Journal:  Am Fam Physician       Date:  2003-04-15       Impact factor: 3.292

7.  The relationship between ventricular ectopic beat frequency and heart rate.

Authors:  R A Winkle
Journal:  Circulation       Date:  1982-08       Impact factor: 29.690

8.  Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia.

Authors:  Kazuo Ueda; Kazufumi Nakamura; Takeharu Hayashi; Natsuko Inagaki; Megumi Takahashi; Takuro Arimura; Hiroshi Morita; Yasushi Higashiuesato; Yuji Hirano; Michio Yasunami; Shuichi Takishita; Akira Yamashina; Tohru Ohe; Makoto Sunamori; Masayasu Hiraoka; Akinori Kimura
Journal:  J Biol Chem       Date:  2004-04-30       Impact factor: 5.157

9.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

10.  Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.

Authors:  Rachel Lampert; Jeannette R Ickovics; Catherine J Viscoli; Ralph I Horwitz; Forrester A Lee
Journal:  Am J Cardiol       Date:  2003-01-15       Impact factor: 2.778

View more
  5 in total

1.  Delayed Chronotropic Response due to Autonomic Imbalance Presenting as Dyspnea on Early Exertion: A Complication of Bariatric Surgery.

Authors:  Shazib Sagheer; Abu Baker Sheikh; Mohammed Alkubeysi; Paul Andre; Christopher Bunn; Shmuel Inbar
Journal:  Cureus       Date:  2018-08-27

2.  PM2.5 induced cardiac hypertrophy via CREB/GSK3b/SOS1 pathway and metabolomics alterations.

Authors:  Kuan-Lun Li; Yen-Chang Lin
Journal:  Oncotarget       Date:  2018-07-20

3.  Leptin Modifies the Rat Heart Performance Associated with Mitochondrial Dysfunction Independently of Its Prohypertrophic Effects.

Authors:  Edna Berzabá-Evoli; Cecilia Zazueta; Jarumi Hishel Cruz Hernández; Nancy Patricia Gómez-Crisóstomo; Isela Esther Juárez-Rojop; Erick Natividad De la Cruz-Hernández; Eduardo Martínez-Abundis
Journal:  Int J Endocrinol       Date:  2018-08-01       Impact factor: 3.257

4.  In vitro effect of leptin on human cardiac contractility.

Authors:  Ryan Chaban; Katja Buschmann; Ahmed Ghazy; Alicia Poplawski; Nadja Wittmann; Andres Beiras-Fernandez; Christian-Friedrich Vahl
Journal:  J Nutr Sci       Date:  2019-04-10

5.  Leptin Is Not Essential for Obesity-Associated Hypertension.

Authors:  Julia von Schnurbein; Jaida Manzoor; Stephanie Brandt; Friederike Denzer; Katja Kohlsdorf; Pamela Fischer-Posovszky; Mario Weißenberger; Sabine Frank-Podlech; Saqib Mahmood; Martin Wabitsch
Journal:  Obes Facts       Date:  2019-07-29       Impact factor: 3.942

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.